Genentech, Roche Settle With PDL BioPharma Over Licensing
Biotechnology giant Genentech Inc. and its parent, F. Hoffmann-La Roche Ltd., have reached an agreement with patent licensing company PDL Biopharma Inc. over pharmaceutical royalties, ending Nevada state court litigation and...To view the full article, register now.
Already a subscriber? Click here to view full article